Gilead Sciences (GILD) Return on Sales (2009 - 2026)
Gilead Sciences' (GILD) quarterly Return on Sales came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and down 8.97% on a QoQ basis from 0.0% in Q4 2025.
Gilead Sciences (GILD) Return on Sales (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales declined to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 0.01% in Q1 2024.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales slipped 1 bps — and 2025, when it gained 1 bps.
- Tracing GILD's Return on Sales over 5 years: stood at 0.0% in 2022, then retreated by 10 bps to 0.0% in 2023, then gained by 18 bps to 0.0% in 2024, then soared by 35 bps to 0.0% in 2025, then retreated by 9 bps to 0.0% in 2026.
- The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.00% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -0.01% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.00% |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |